Evidence map›Paper›PMID 37835485›Full record

ArticleCancers2023

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series.

Sim Vermeulen, Katrien De Keukeleire, Nicole Dorny, Isabelle Colle, Bert Van Den Bossche, Victor Nuttens, Dirk Ooms, Pieter De Bondt, Olivier De Winter

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sim VermeulenNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Katrien De KeukeleireInterventional Radiology Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Nicole DornyNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Isabelle ColleGastroenterology Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Bert Van Den BosscheAbdominal Surgery Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Victor NuttensNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.ORCID 0000-0002-6797-8789
Dirk OomsNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Pieter De BondtNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.
Olivier De WinterNuclear Medicine Department, A.S.Z. Aalst, 9300 Aalst, Belgium.

Funding

Terumo (Belgium) Open acces fee
6 · The paper itself

Abstract

backgroundTransarterial radioembolization (TARE) is used to treat primary and secondary malignancies in the liver that are not amenable to curative resection. Accumulating evidence demonstrates the efficacy and safety of TARE with yttrium-90 (

methodsThis was a retrospective case series study of seven consecutive patients with ICC who were treated with

resultsThree out of the seven patients had a partial or complete response. Two patients had stable disease after the first TARE procedure, and two of the patients (one with a complete response, and one with stable disease) were alive at the time of analysis. No serious adverse events related to the procedure were recorded.

conclusionsThis is the first case series reporting the safety and tumor response outcomes of

Indexed as

holmiumintrahepatic cholangiocarcinomasafetyselective internal radiation therapy (SIRT)transarterial radioembolization (TARE)

Identifiers

PMID37835485
PMCPMC10571855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.